
A group of JUUL Labs investors has raised concerns about a financial relief transaction conducted by JUUL board members Nick Pritzker and Riaz Valani in November 2022, according to The Wall Street Journal. They allege that the deal has benefited insiders while harming the interests of other investors.
As a pioneer in the e-cigarette industry, JUUL Labs has shifted from dominating the American market to fighting for survival in a short period of time. After achieving initial success, the company faced regulatory scrutiny due to its marketing practices. Thousands of lawsuits alleging that the company facilitated an "epidemic" of e-cigarette use among minors have notably impacted its financial situation.
JUUL is considering bankruptcy since June 2022, after the FDA ordered the removal of its e-cigarettes from the market and obtained a court injunction.
In order to avoid bankruptcy, Pritzker and Valani refinanced JUUL's loan deadlines in September 2022 and subsequently loaned funds to cover operational costs during the autumn. Finally, the two directors, along with JUUL's co-founders James Monsees and Adam Bowen, supported a comprehensive legal and investment agreement, which involved equity investment in JUUL.
JUUL successfully raised $1.27 billion in funding in October 2023, after engaging with numerous potential investors. This funding includes an additional $45 million investment from Pritzker, Valani, and two co-founders of JUUL, as well as legal entities associated with JUUL and four other investors.
Entities associated with Valani and Pritzker now collectively hold nearly half of JUUL's shares, while the majority of other investors have significantly reduced their holdings during the crisis.
D1 Capital Partners, an affiliate of hedge fund, along with two other investors, filed a lawsuit against JUUL in October 2023, alleging that Pritzker and Valani "exploited the company's distress to further their own personal interests, thereby harming other stakeholders of JUUL.
JUUL plans to raise $330 million in 2024 to maintain its existing product line in the US market and submit new e-cigarette products for federal authorization.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com